Aprl Pathlabs Profile
Key Indicators
- Authorised Capital ₹ 6.00 M
as on 11-12-2024
- Paid Up Capital ₹ 0.63 M
as on 11-12-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 25.01%
(FY 2022)
- Profit -25.31%
(FY 2022)
- Ebitda -18.48%
(FY 2022)
- Net Worth 19.15%
(FY 2022)
- Total Assets 12.56%
(FY 2022)
About Aprl Pathlabs
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 M and a paid-up capital of Rs 0.63 M, as per Ministry of Corporate Affairs (MCA) records.
Ved Goel, Shankha Banerjee, and Subhash Padmani serve as directors at the Company.
- CIN/LLPIN
U85195GJ2019PTC110176
- Company No.
110176
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 2019
- Date of AGM
27 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Aprl Pathlabs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ved Goel  | Director | 13-Nov-2019 | Current |
| Shankha Banerjee | Director | 19-Nov-2021 | Current |
| Subhash Padmani | Whole-Time Director | 04-Oct-2019 | Current |
Financial Performance and Corporate Structure Insights of Aprl Pathlabs.
Aprl Pathlabs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.01% increase. The company also saw a substantial fall in profitability, with a 25.31% decrease in profit. The company's net worth Soared by an impressive increase of 19.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aprl Pathlabs?
In 2023, Aprl Pathlabs had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Suburban Diagnostics (India) Private LimitedActive 22 years 6 monthsVed Goel and Shankha Banerjee are mutual person
Chanre Laboratory Private LimitedActive 3 years 11 monthsVed Goel and Shankha Banerjee are mutual person
Centrapath Labs Private LimitedActive 5 years 5 monthsVed Goel and Shankha Banerjee are mutual person
- Pathlabs Unifiers Private LimitedActive 6 years 9 days
Ved Goel and Shankha Banerjee are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Aprl Pathlabs?
Aprl Pathlabs has a workforce of 61 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aprl Pathlabs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aprl Pathlabs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
